(Q36616182)

15 August 2017

1 reference

title

Fungal pneumonia due to molds in patients with hematological malignancies (English)

1 reference

15 August 2017

1 reference

1 reference

Pagano L

1

1 reference

15 August 2017

Fianchi L

series ordinal

2

1 reference

15 August 2017

Leone G

series ordinal

3

1 reference

15 August 2017

publication date

1 August 2006

1 reference

15 August 2017

published in

Journal of Chemotherapy

1 reference

15 August 2017

volume

18

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

339-352

1 reference

Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Risk factors and attributable mortality associated with superinfections in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Fungal pneumonias in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Invasive yeast infections other than Candida spp. in acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

The epidemiology of fusariosis in patients with haematological diseases. Gimema Infection Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Colonization and infection with Trichosporon species in the immunosuppressed host

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Pneumocystis carinii pneumonia in patients with hematologic malignancies: a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Epidemiology of Aspergillus terreus at a university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Nosocomial aspergillosis: a retrospective review of airborne disease secondary to road construction and contaminated air conditioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

An outbreak of invasive aspergillosis in a haematologic unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Molecular epidemiology of Aspergillus fumigatus isolates recovered from water, air, and patients shows two clusters of genetically distinct strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Disseminated phaeohyphomycosis: review of an emerging mycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Operation for cavitating invasive pulmonary aspergillosis in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Published rather than proposed definitions for invasive fungal infection must be applied to allow standardization in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Early chest radiography and CT in the diagnosis, management and outcome of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Galactomannan detection in computerized tomography‐based broncho‐alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Crescent sign in invasive pulmonary aspergillosis: frequency and related CT and clinical factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Pulmonary cryptococcosis: CT and pathologic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Bifidobacterial lipoglycan as a new cause for false-positive platelia Aspergillus enzyme-linked immunosorbent assay reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Percutaneous transthoracic needle aspiration: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Therapeutic outcome in invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Amphotericin B: time for a new "gold standard".

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Combination antifungal therapy for invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Clinical perspectives of granulocyte transfusions: efficacy to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Pulmonary mucormycosis: results of medical and surgical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Primary cutaneous zygomycosis due to Saksenaea vasiformis and Apophysomyces elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Infection due to Rhizomucor pusillus: report of four cases in patients with leukemia and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

In vitro susceptibility to 9 antifungal agents of 14 strains of Zygomycetes isolated from clinical specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Voriconazole: a new triazole antifungal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Successful treatment of mucor infection after liver or pancreas-kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Lung scedosporiosis: a differential diagnosis of aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Successful treatment of disseminated fusariosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Successful treatment of pneumonia due to Scedosporium apiospermum with itraconazole: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Review of the safety and efficacy of voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Progress in fighting systemic fungal infections in haematological neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Comparison of Serum Galactomannan Antigen Detection and Competitive Polymerase Chain Reaction for Diagnosing Invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

The Role of Bronchoalveolar Lavage in the Microbiological Diagnosis of Pneumonia in Patients with Haematological Malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.339

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1086/422009

Identifiers

DOI

10.1179/JOC.2006.18.4.339

1 reference

release_wcfx76wofzce3otmd47ukf6tla

15 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wcfx76wofzce3otmd47ukf6tla

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference